Leadership

Inventor of the IUB™, Dr. Ilan Baram is the founder and Medical Director of OCON Healthcare.

Dr. Baram is a senior gynecologist specializing in contraception.

Dr. Ilan Baram, MD Inventor of the IUB™, Dr. Ilan Baram is the founder and Medical Director of OCON Healthcare. Dr. Baram is a senior gynecologist specializing in contraception.

Dr. Eran Nir, PhD

Dr. Eran Nir, OCON's CTO, is responsible for the company's R&D and technology aspects, relying on his extensive development and pre-clinical expertise in companies such as J&J and Chiasma Pharma.

Dr. Nir holds a PhD in Biology.

Dr. Eran Nir, PhD Dr. Eran Nir, OCON's CTO, is responsible for the company's R&D and technology aspects, relying on his extensive development and pre-clinical expertise in companies such as J&J and Chiasma Pharma. Dr. Nir holds a PhD in Biology.

Orna Landau

Orna Landau is OCON's Director QA & Regulations and brings years of experience in regulatory and quality assurance work in the pharma and drug-device industries.

Ms. Landau holds a MA in Law and Biotechnology.

Orna Landau Orna Landau is OCON's Director QA & Regulations and brings years of experience in regulatory and quality assurance work in the pharma and drug-device industries. Ms. Landau holds a MA in Law and Biotechnology.

Noa Chachkes

Ms. Noa Chachkes, Administrative Manager & HR Supervisor, has been with OCON since 2013 and has gained substantial experience in the company's logistics and administrative roles.

Ms. Chachkes holds a BA in Management of Service Organizations & Human Resources.

Noa Chachkes Ms. Noa Chachkes, Administrative Manager & HR Supervisor, has been with OCON since 2013 and has gained substantial experience in the company's logistics and administrative roles. Ms. Chachkes holds a BA in Management of Service Organizations & Human Resources.

Ariel Weinstein

Mr. Ariel Weinstein, OCON's CEO, has over 2 decades of international experience in the clinical and medical development fields and has held leadership positions since 2006.

Mr. Weinstein holds a BSc in Emergency Medicine and a MSc in Management from NYU-Poly.

Ariel Weinstein Mr. Ariel Weinstein, OCON's CEO, has over 2 decades of international experience in the clinical and medical development fields and has held leadership positions since 2006. Mr. Weinstein holds a BSc in Emergency Medicine and a MSc in Management from NYU-Poly.

Dr. Ketty Shkolnik, PhD

Ketty Shkolnik, OCON’s VP Clinical Affairs, brings over 10 years of profound experience in clinical research and clinical trial management in the BioMedical industry.

Dr. Shkolnik holds a Ph.D. in Life Sciences from the Weizmann Institute of Science.

Dr. Ketty Shkolnik, PhD Ketty Shkolnik, OCON’s VP Clinical Affairs, brings over 10 years of profound experience in clinical research and clinical trial management in the BioMedical industry. Dr. Shkolnik holds a Ph.D. in Life Sciences from the Weizmann Institute of Science.

Meir Rimer

Mr. Meir Rimer, Operations Manager, has well over ten years of experience in biomedical companies such as Macrocure and Glycominds.

Mr. Rimer has a BSC in Chemistry of Materials and a MBA.

Meir Rimer Mr. Meir Rimer, Operations Manager, has well over ten years of experience in biomedical companies such as Macrocure and Glycominds. Mr. Rimer has a BSC in Chemistry of Materials and a MBA.

Amir Avraham, CPA

Mr. Amir Avraham, CFO of OCON Healthcare, hails from Secure Islands, a company acquired by Microsoft, and prior to that was CFO of Van Leer Ventures Jerusalem.

A certified accountant, Mr. Avraham has a BA in Accounting & Economics and a MBA.

Amir Avraham, CPA Mr. Amir Avraham, CFO of OCON Healthcare, hails from Secure Islands, a company acquired by Microsoft, and prior to that was CFO of Van Leer Ventures Jerusalem. A certified accountant, Mr. Avraham has a BA in Accounting & Economics and a MBA.

Bettina Münz

Bettina Münz, OCON's VP Marketing & Sales, brings over 20 years of global experience in introducing new technology to the medical device and pharma industry with Medtronic, Johnson & Johnson, Pfizer, Eli Lilly & Roche.

Ms. Münz holds a B.Ed. and M.Sc. from Sackler School of Medicine.

Bettina Münz Bettina Münz, OCON's VP Marketing & Sales, brings over 20 years of global experience in introducing new technology to the medical device and pharma industry with Medtronic, Johnson & Johnson, Pfizer, Eli Lilly & Roche. Ms. Münz holds a B.Ed. and M.Sc. from Sackler School of Medicine.

Daniela Schardinger

Ms. Daniela Schardinger, European Operations, has well over 10 years of experience in Marketing, Sales and Management in the legal and pharmaceutical industry around the globe.

Ms. Schardinger holds a MSc in Information Design and Marketing.

Daniela Schardinger Ms. Daniela Schardinger, European Operations, has well over 10 years of experience in Marketing, Sales and Management in the legal and pharmaceutical industry around the globe. Ms. Schardinger holds a MSc in Information Design and Marketing.

Board of Directors

Charles Woler, MD, PhD | Chairman

Dr. Woler is a present and former pharmaceutical, medical device and VC fund executive in multiple high profile international companies.

Ilan Baram, MD

Inventor of the IUB™, Dr. Ilan Baram is the founder and Medical Director of OCON Healthcare. Dr. Baram is a senior gynecologist specializing in contraception.

Tomer Kariv

Co-founder and Chief Executive Officer of Pontifax. Tomer serves as a board member at Eloxx Pharmaceuticals, LogicBio Therapeutics, VBI Vaccines, Cathworks and V-Wave among others and holds a B.A. in Economics from Harvard University and a J.D. from Harvard Law School.

Asaf Shinar, CPA

Mr. Shinar is the CFO of The Pontifax Group. The fund runs more than 50 portfolio companies all around the globe.

Adi Goldin, LLB

Mr. Goldin is Docor's Vice President and has over 15 years of experience in the life science, industrial and hi-tech industries in the areas of investments, business strategy, deal structure and company management. Mr. Goldin holds a Masters in Economics as well as a LLB.

Yann Brun

Mr. Brun, has been Managing Director of Exeltis, the Pharma Division of INSUDPHARMA, since October 2017. Previously he was Head of International and BD for Exeltis. Before joining INSUPHARMA in 2015, Yann worked as Commercial Director Europe, Head of New Products Expansion and BD&L Director at Abbott.

Pavel Rodyukov

Investment Director at RUSNANO Management Company since 2008, Mr. Rodyukov is a board member at Trackpore Technology, Mitotech and RMI.

"OCON is exciting and unique in its solutions and especially by its strong team basically creating a new field in women’s health."

Dr. Charles Woler, MD, PhD | Chairman

Advisory Board

Prof. James Trussell

One of the world‘s foremost experts on family planning with particular expertise in contraceptive effectiveness and cost effectiveness. James Trussell was Professor of Economics and Public Affairs and Faculty Associate at the Office of Population Research at Princeton University as well as a visiting Professor at The Hull York Medical School. Prof. Trussel had over 300 published peer reviewed papers and numerous professional affiliations.

James Trussell sadly passed away on December 26, 2018 after a short illness. We are thankful for his continued support as one of OCON’s early advisory board members. Our condolences to his family, friends and colleagues.

Dr. David Hubacher, PhD

A world renowned expert and key opinion leader on contraceptive methods and IUDs in particular, Dr. Hubacher serves as a senior scientist at Family Health International (FHI360). David Hubacher has over 25 years research experience, authored dozens of key peer reviewed publications and speaks at conferences worldwide. Dr. Hubacher received his M.P.H. in Biostatistics and his Ph.D. in Epidemiology from UNC Chapel Hill.

Dr. Amos Ber, MD

A senior Ob/Gyn, Dr. Ber has authored over 40 peer reviewed papers and has extensive experience with hormonal IUDs, lecturing on their use globally. Amos Ber is on the Board of the Israeli Society of Contraception and Sexual Health, Israeli Society of Menopause and the European society of contraception and reproductive health (ESC). Dr. Ber graduated from the Sackler faculty of medicine at the Tel Aviv University.

Dr. Valerie Tarico, PhD

Dr. Tarico is deeply involved in reproductive rights and improving access to top tier contraceptives. Valerie Tarico serves on the Board of Advocates for Youth, a D.C. based nonprofit with programs related to reproductive health and serves on Planned Parenthood‘s Board of Advocates. Dr. Tarico's articles appear on sites including the Huffington Post and the Institute for Ethics and Emerging Technologies.

Dr. Morris Wortman, MD

Dr. Wortman serves on the Editorial Board for the Journal of Minimally Invasive Gynecology and is an internationally respected authority on the subject of late-onset endometrial ablation failures, sonographically guided hysteroscopic surgery and office-based gynecologic surgery. He serves as Associate Clinical Professor of Gynecology at the University of Rochester.

OCON

Welcome to OCON Healthcare